成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

3-chloro-5-ethoxypyridine-4-carbonitrile

3-chloro-5-ethoxypyridine-4-carbonitrile Struktur
153463-57-1
CAS-Nr.
153463-57-1
Englisch Name:
3-chloro-5-ethoxypyridine-4-carbonitrile
Synonyma:
3-chloro-5-ethoxyisonicotinonitrile;3-Chloro-5-ethoxy-4-pyridinecarbonitrile;3-chloro-5-ethoxypyridine-4-carbonitrile;4-Pyridinecarbonitrile, 3-chloro-5-ethoxy-
CBNumber:
CB72616356
Summenformel:
C8H7ClN2O
Molgewicht:
182.61
MOL-Datei:
153463-57-1.mol

3-chloro-5-ethoxypyridine-4-carbonitrile Eigenschaften

Siedepunkt:
307.2±37.0 °C(Predicted)
Dichte
1.27±0.1 g/cm3(Predicted)
pka
-0.43±0.10(Predicted)

Sicherheit

3-chloro-5-ethoxypyridine-4-carbonitrile Chemische Eigenschaften,Einsatz,Produktion Methoden

3-chloro-5-ethoxypyridine-4-carbonitrile Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3-chloro-5-ethoxypyridine-4-carbonitrile Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 12)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Blocksynth Pharmaceutical Technology Co.,Ltd 		0086-19817745290; +8619817745290
 bd@blocksynth.com China 5659 58
Hangzhou MolCore BioPharmatech Co.,Ltd. 		+86-057181025280; +8617767106207
 sales@molcore.com China 49734 58
Bellen Chemistry Co., Ltd. 010-60400365-8001 15910885229
 service@bellenchem.com China 4508 60
Shanghai Haohong Pharmaceutical Co., Ltd. 4008210725 4008210725
 malulu@leyan.com China 54987 58
Bide Pharmatech Ltd. 400-1647117 13681763483
 product02@bidepharm.com China 62075 58
Bide Pharmatech Ltd. 400-6005915
sales@picasso-e.com China 39653 58
Zhuhai Aobokai Biomedical Technology Co., Ltd. 400-0628126 15697565236;
 sales-team@aobchem.com.cn China 50190 58
Ningbo Zhenyue Pharmaceutical Technology Co., Ltd 19817745290
 bd@blocksynth.com China 5662 58
  • 3-chloro-5-ethoxypyridine-4-carbonitrile
  • 4-Pyridinecarbonitrile, 3-chloro-5-ethoxy-
  • 3-chloro-5-ethoxyisonicotinonitrile
  • 3-Chloro-5-ethoxy-4-pyridinecarbonitrile
  • 153463-57-1
Copyright 2019 ? ChemicalBook. All rights reserved